Bridgeway Capital Management, LLC Ligand Pharmaceuticals Inc Transaction History

Bridgeway Capital Management, LLC

  • $4.14 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$86.25 - $120.16 $457,125 - $636,848
-5,300 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$107.38 - $129.34 $53,690 - $64,670
-500 Reduced 8.62%
5,300 $605,000
Q1 2019

May 15, 2019
BUY
$105.93 - $142.47 $614,394 - $826,326
5,800 New
5,800 $729,000

Others Institutions Holding LGND

# of Institutions
247
Shares Held
17.5M
Call Options Held
61K
Put Options Held
7.8K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.69B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email